The kinetics of cleavage of pr929P, the precursor of the two glycoproteins of Rous sarcoma virus gp85 and gp35, were followed. Viral glycoproteins were detected by immunoprecipitation with anti-gp85 and anti-gp35 serum. It could be shown in pulse-chase experiments that little or no intracellular cleavage of the precursor took place during the time in which the majority of newly synthesized viral glycoprotein was exported from the cells. Soon after its synthesis, however, pr929P underwent some modification that made it migrate slightly faster on sodium dodecyl sulfate-polyacrylamide gels. Under steady state conditions the precursor was shown to be the predominant form of intracellular viral glycoprotein. Virus which was harvested every 2 min from infected cells prelabeled for 90 min with [3H]mannose contained mostly uncleaved and only a little mature glycoprotein. By incubation of this freshly released virus in serum-free buffer, the majority of the glycoprotein precursor could be cleaved into mature gp85 and gp35. Virus harvested every 10 min contained only mature glycoproteins.
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RNA tumor viruses bud from the plasma membrane of cells in a morphologically immature form and undergo subsequent extracellular maturation (for review, see reference 2). Several molecular transformations occur concomitantly with these morphological changes (16) . One of these maturation processes is the assembly of two 30 to 40 S subunits of the viral RNA to form the mature 70 S complex (8, 11, 16) . The precursor of the reverse transcriptase, a polypeptide of 180,000 molecular weight containing, in addition to the sequences of the polymerase, those of the group-specific proteins (gag), also undergoes processing after budding (22) . The polymerase shows no enzymatic activity in immature particles (9) .
In contrast to these extracellular maturation processes, pr76, the precursor of the gag proteins of avian sarcoma viruses, is processed intracellularly (12, 29, 30) . The gag precursor of murine leukemia virus, P70 (21, 24, 28) , is also intracellularly processed, but cleavage seems to be less efficient, and about 10% of the gag proteins in particles is found in an uncleaved form (24) .
Virions enriched in P70 have a morphology which is typical for immature particles. They contain a proteolytic activity which can cleave P70 in vitro, and this cleavage is associated with morphological changes (35) . A mutant of Rauscher murine leukemia virus (ts25) has been demonstrated to encapsidate only the uncleaved gag precursor into virus particles (1) .
The existence in Rous sarcoma virus (RSV) of a high-molecular-weight glycoprotein precursor has been reported earlier (7, 13, 15, 19, 25) . It has been shown that this polypeptide (pr92'P) contains the sequences of the two envelope glycoproteins gp85 and gp35 (15, 25) . Their arrangement on the common precursor has also been established (15, 25) . gp85 is located in the Nterminal position, and gp35 is located in the Cterminal position of the precursor. Contradictory data have been published about the site of cleavage of the precursor. The experiments of Buchhagen and Hanafusa do not show intracellular cleavage of the precursor (7), whereas Moelling and Hayami (19) and England et al. (13) (26) . Samples were applied to the concanavalin A-Sepharose column in lysis buffer (20 mM Tris-hydrochloride, pH 7.4, 50 mM NaCl, 0.5% NP-40, 0.5% deoxycholate). The column was washed extensively with TS buffer (10 mM Tris-hydrochloride, pH 8.7 , 100 mM NaCi) containing 1% deoxycholate, and bound proteins were eluted with the same buffer containing 1 M a-methylglucopyranoside.
RESULTS
Rate of export of viral glycoprotein from Pr RSV-C-infected chicken embryo fibroblasts. To study the extent of intracellular processing, the time course of export of pr92g" from the cell has to be known. It (Fig. 1E ) only very little glycoprotein (14% of radioactivity) remained inside the cell. During the whole chase time no intracellular gp35 was observed, an indication of the lack of precursor cleavage (see below).
The amount of glycoprotein in viral particles purified from the supernatant increased in parallel with the decrease of intracellular viral glycoprotein ( Fig. 1B ' through E'). In contrast to the cell lysate, gp35 was easily detected in the virus.
Kinetics of intracellular cleavage of pr929P. The experiments described above reveal that at a few hours after synthesis the majority of viral glycoprotein is exported from the cells. To determine whether and at what rate intracellular cleavage of the precursor takes place, a pulse-chase experiment was performed with chase times of up to 6 h.
Because pr929P and gp85 are not well resolved in normal SDS-polyacrylamide gels, a 20-cm gel with an exponential gradient of polyacrylamide from 8 to 18% was chosen for the analysis of the immunoprecipitates. This type of gel gives a very good resolution in the high-molecularweight range and still separates low-molecularweight proteins such as gp35, although to a lesser extent.
Labeling was performed in Earle medium with [3H]mannose for 15 min. Cells which were to be chased for longer periods of time were labeled with a higher amount of radioactivity in order to still see possible late cleavage irrespective of the absolute amount of radioactive viral glycoproteins left in the cells at that time. After pulselabeling, the cells were incubated in Eagle medium for different periods of time and lysed, and viral glycoproteins were immunoprecipitated with anti-gp85 or anti-gp35 serum.
The results presented in Fig. 2 reveal that after the pulse-labeling the intracellular viral glycoprotein existed exclusively as pr929P, which was immunoprecipitable with anti-gp85 (Fig. 2b) as well as with anti-gp35 serum (Fig. 2c) .
During the whole chase time, however, the immunoprecipitates contained a protein which migrated slightly faster than pr929P but did not comigrate with gp85 from virus particles purified from the supernatants after the different chase periods (Fig. 2a, j, and k) . This new protein, which we call pr909P, was recognized by antigp85 serum (Fig. 2d , e, g, and h) as well as by anti-gp35 serum ( Fig. 2f and i) and contained, therefore, both the gp85 and gp35 sequences.
The migration in SDS-polyacrylamide gels of pr929P was directly compared with that of pr909P (Fig. 3) respect the two proteins differ other than their migration in SDS-polyacrylamide gels.
Steady state of intracellular viral glycoproteins. The experiments presented so far suggest that there is little or no intracellular cleavage of the glycoprotein precursor. Therefore, the precursor is expected to be the predominant viral glycoprotein species in the cell under steady state conditions. The steady state level of viral glycoproteins was determined under conditions where incorporation of label was constant. The label chosen was [3H]mannose because it guarantees a very low level of nonviral contaminants in the immunoprecipitates since only glycoproteins will be labeled. For this experiment the amount of [3H]mannose label in the precursor compared with the amount in gp85 must be known because it is possible that the glycoprotein acquires or loses mannose residues during maturation and processing. From the analysis of the tryptic peptides of methioninelabeled viral glycoprotein, it is known that gp85 contains two to three times more methionine residues than does gp35 (15) . Assuming a molecular weight for gp85 of approximately two to three times that of gp35, we can conclude that both proteins have a similar percentage of methionine residues. This is also true for pr92BP because it has no additional methionine residues (unpublished data). The amount of label in methionine can therefore be taken as a measure of the amount of protein in each of the three viral glycoproteins. If the ratio of mannose to methionine is the same, then the amount of label in mannose is also directly related to the amount of protein. We thus determined this ratio for pr929P and gp85 by labeling these proteins with [3H]mannose and [35S]methionine simultaneously. From the data in Table 1 it can be concluded that pr925P and gp85 contain approximately the same number of mannose residues per methionine residue and that the amount of mannose label can indeed be taken as a measure for the amount of protein when these two proteins are compared. To The results of this experiment are presented in Fig. 4 . The major [3H]mannose-labeled protein comigrated with [35S]methionine-labeled pr929P, which was added as a marker. A small quantity of gp85 and gp35 was present. Whether the high-molecular-weight protein represents pr929P or pr909P or a mixture of both cannot be discemed because the peak is broad and overlaps the gp85 peak.
When this experiment was repeated with a labeling period of only 7.5 h, the same gel pattem as that in Fig. 4 was obtained (data not shown). Because 7.5 h and 9 h of labeling gave the same result, we concluded that steady state conditions were reached. This data indicates that at least 75% of the precursors pr929P and pr909P is uncleaved during the steady state conditions. We cannot exclude the possibility that some of the gp85 and gp35 found in the cell lysates is present due to contamination of cells with readsorbed virus from the medium.
Glycoprotein composition of freshly released virus. The fact that cleavage of the glycoprotein precursor is slower than its incorporation into virus particles suggests that some of the glycoprotein should appear in the virion in the uncleaved form. To test this hypothesis, Pr RSV-C-infected cells were prelabeled for 90 min with [3H]mannose, and for the following 3 h the medium was replaced every 2 min and frozen immediately. The pooled medium was thawed, cell debris was removed by low-speed centrifugation, and the-virus-was pelleted by ultracentrifugation. The pellet was dissolved in sample buffer and applied to a gradient polyacrylamide gel. The result of such an experiment is shown in Fig. 5 . As expected, freshly budded virus did contain some glycoprotein which comigrated with the phosphorylase a marker, that is, to the position of the glycoprotein precursor (Fig. 5A) . Some [3H]mannose-labeled material comigrated with the [35S]methionine-labeled gp85 marker run in the same slot, indicating that some glycoprotein precursor had already been cleaved.
When the virus was harvested every 10 min instead of every 2 min, the majority of labeled protein migrated as gp85 and gp35 (Fig. 5B) . We conclude that very fresh virus still contained some precursor glycoprotein, which was cleaved within 10 min in the virion.
When the virus harvested every 2 incubated in PBS for 90 mim at 370C, the amount of precursor decreased considerably, but the processing seemed incomplete (Fig. 50) . The same was true when the harvested medium was incubated at 37°C for 90 min after thawing and before purification of the virus (Fig. 5D) . Freezing, therefore, might partially inactivate the protease responsible for processing of the precursor. The fact that processing in PBS alone was possible indicated that the presence of factors in the medium was not required and suggests that the protease involved in processing is associated with virus particles.
DISCUSSION
In an earlier publication we showed that pr929P contains the arginine-labeled tryptic peptides of gp85 and gp35 (15) , and this data has been confirmed recently by Shealy and Rueckert (25) . These results suggest that pr929P is the precursor of gp85 and gp35, but kinetic data are needed to show the simultaneous and quantitative disappearance of pr929P and the appearance of gp85 and gp35. Such kinetics would make it very likely that pr929P is the functional precursor for the two viral glycoproteins. Kinetic experiments have been performed previously by a number of other groups. Some could demonstrate intracellular cleavage of pr929P (13, 19) , and others could not (7) .
From the results presented in this paper, we come to the conclusion that extracellular cleavage is the predominant way of pr929P processing.
We first performed pulse-chase experiments to determine whether and to what extent intracellular cleavage of pr929P takes place. The results presented in Fig. 1 show that the glycoprotein started to be released from cells after about 1 h and that the majority of the labeled glycoprotein was exported by 4 h. This result is in agreement with findings made with murine leukemia virus (14, 33) . The intracellular glycoproteins in this experiment were analyzed on a 15% polyacrylamide gel, which does not allow separation of pr929P and gp85. Mature intracellular viral glycoprotein has been shown to exist as a disulfide-linked complex of gp85 and gp35 (17) . Although gp35 alone is not recognized by our anti-gp85 serum, it is immunoprecipitated when linked in this way. The almost complete absence of gp35 in immunoprecipitates even after a prolonged chase period (Fig. 1C through E) is evidence for the lack of intracellular viral glycoprotein and therefore for the lack of cleavage. This fmding is supported by the result of a second pulse-chase experiment in which the immunoprecipitates were analyzed on a long exponential gradient gel to allow separation of pr929P from gp85. No gp85 was visible inside the cell even after a chase period of up to 6 h ( Fig. 2h and i) . When this experiment was repeated several times with different cell cultures, we sometimes observed cleaved glycoproteins in cell lysates. During short chase times (up to 3 h) intracellular cleavage was always negligible. After longer chase times, when only a small percentage of the immunoprecipitable radioactivity remained in the cell, we sometimes detected up to 50% of the label in the form of cleaved viral glycoproteins. In these experiments we were unable to exclude the possibility of contamination of our cell lysate with mature virus particles readsorbed to the cell surface. From all of our data we conclude that most of the glycoprotein precursor is not cleaved inside the cell. Our conclusion differs from that of Witte et al. (32) , who suggested that sialidation and cleavage of pr8O, the glycoprotein precursor of murine leukemia virus, are signals for budding of the virus.
In agreement with the results of the pulsechase experiments is our finding that the amount of precursor under steady state conditions is very high, compared with the amount of gp85 and gp35 (Fig. 4) .
It could be imagined that processing of the precursor is a fast but very late process which happens just before release of the viral particles. That this is not the case is demonstrated by the finding that newly budded virus still contained the majority of its glycoprotein in the uncleaved form (Fig. 5A) . The cleavage of the glycoprotein precursor is a slow process before formation of the virus particle, but a fast one thereafter. Almost complete cleavage of the precursor occurred within 10 min of release of the virion from the cell (Fig. 5B) , whereas complete intracellular cleavage did not occur even after 6 h ( Fig. 2h and i) . A possible explanation for this phenomenon is that the precursor and the proteolytic factor come together at a very late stage in virus assembly. Because pr929P is likely to be translated on membrane-bound polysomes and transported through the membranes (4), it might reach the plasma membrane without ever having been in contact with other viral proteins. It may come into close contact with the viral core only during the budding process. This could be the moment when cleavage starts. The viral core protein p15 is a candidate protease, because it has been shown to cleave specifically the gag precursor (31) . p19 is another candidate because some of it has been found associated with viral glycoproteins (20, 23) and may be embedded in the membrane. This latter point is important because it is most likely that at least half of the gp85 molecules are attached to the virus only through disulfide bonds to gp35 which is tightly associated with the membrane (5, 20; Diggelmann, manuscript in preparation). This suggests that the cleaving point of the precursor is on or near the outside of the envelope and accessible for only a membrane protease. However, it is also possible that the cleaving point is at the inside of the viral envelope in immature virions and that cleavage changes the conformation of gp85 in such a way that its newly created Cterminal end is pushed through the membrane. Cleavage also occurs when immature virus particles are incubated in buffer alone (Fig. 5C ). This argues against the possibility that cleavage is performed by a soluble protease from the medium as in the case of the hemagglutinin precursor of influenza virus which is processed by plasmin (10). We do not exclude the possibility that a nonviral protein acts as the protease because the virion contains many cellular proteins. Such a situation seems to exist in murine leukemia virus, in which processing of the gag precursor P70 is performed by a proteolytic factor not identical with any known viral protein (34) .
Experiments are being performed in this laboratory to determine which protein is involved in the cleavage of the glycoprotein precursor.
